BT

Beam Therapeutics

Organization

Heard in 4 episodes across 4 shows since Apr 2026

Beam Therapeutics is a biotechnology company developing precision genetic medicines using base-editing technology to treat serious diseases.

Episodes

4
across 4 shows

First heard

Apr 2026

Expert statements

3
1 negative

Episodes per month

Public PodLume episodes featuring it, over the last year.

Show the data
MonthEpisodes
Dec 20250
Jan 20260
Feb 20260
Mar 20260
Apr 20261
May 20260
Jun 20260
Jul 20260
Aug 20260
Sep 20260
Oct 20262
Nov 20261

Email alert

Email me when Beam Therapeutics comes up on a podcast

One email a week at most, with the new episodes that mention Beam Therapeutics. Free, no account needed, unsubscribe in one click.

What experts have said about Beam Therapeutics

3 statements · 1 negative · 1 mixed · 1 neutral

  1. Steve UsdinNeutralOct 6, 2026· BioCentury This Week

    Beam Therapeutics filed a trade-secret lawsuit against Yoltec.

    “Beam Therapeutics filed suit on September 25 in the U.S. District Court for the District of Massachusetts.”

    Listen at 11:49

    Open the episode · Ep. 391 - China deals, Beam lawsuit, MFN models, Nobel winners
  2. Jim CramerNegativeApr 28, 2026· Mad Money w/ Jim Cramer

    Beam Therapeutics is a speculative investment.

    “Beam is a speculative situation.”

    Listen at 36:08

    Open the episode · Mad Money w/ Jim Cramer 4/28/26
  3. Beam should be bought only if its treatment can save many lives.

    “I would buy this if you thought that they've got something that can save a lot of lives. That's it. Otherwise, move on.”

    Listen at 36:17

    Open the episode · Mad Money w/ Jim Cramer 4/28/26

Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.

Episodes

4 episodes featuring Beam Therapeutics, newest first